Redwood City, CA, United States of America

Jean-Francois A Martini

USPTO Granted Patents = 1 


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jean-Francois A Martini

Introduction

Jean-Francois A Martini is a notable inventor based in Redwood City, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the use of specific modulators to inhibit key kinases involved in cancer progression.

Latest Patents

Jean-Francois A Martini holds a patent for a method of using PI3K and MEK modulators. This invention provides methods of treating cancer with a combination of compounds that inhibit kinases, specifically targeting MEK and PI3K. His patent represents a crucial advancement in the fight against cancer, offering new therapeutic options for patients.

Career Highlights

Martini is currently associated with Exelixis, Inc., a company dedicated to developing innovative cancer therapies. His role at Exelixis allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Dana T Aftab and A Douglas Laird. Their collective expertise enhances the research environment at Exelixis, fostering innovation and development in cancer treatment.

Conclusion

Jean-Francois A Martini's work exemplifies the impact of innovative thinking in the medical field. His contributions to cancer treatment through his patent and collaboration with esteemed colleagues highlight the importance of research and development in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…